Work

Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma

Year: 2021

Type: article

Study design: Case Report

Abstract: Angiogenesis inhibitors (AGI) are not presently used for the treatment of gastric cancers. This report demonstrates that angiogenesis inhibitor can be safely and effectively used in combination with cytotoxic anti‐cancer agents for treatment of Gastric cancers.

Source: Clinical Case Reports

DOI: 10.1002/ccr3.4986

Authors: Sewanti Limaye, Darshana Patil, Dadasaheb Akolkar, Navin Srivastava, Revati Patil, Sachin Apurwa, Sanket Patil, Jinumary John, Rahul Gosavi, Prabhu Nesargikar, Prashant Kumar, Vineet Datta, Chirantan Bose, Zarrine Raazi, Ajay Srinivasan, Rajan Datar

Institutions: Kokilaben Dhirubhai Ambani Hospital, Datar Cancer Genetics (India), HCG Cancer Hospital, HCG Cancer Centre, Manipal Academy of Higher Education, Institute of Bioinformatics, Somaiya Vidyavihar University

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,210

OpenAlex ID: W3213057590

FWCI: 0.3

Cites: 28

Cited by: 3

Related to: 10